Events Partner Content Orphan Drugs & Rare Diseases 2018 Orphan Drugs & Rare Diseases 2018 Conference
Events Partner Content Fifth Annual Re-Entering Antibacterial Discovery and Develop... The Summit works to improve antimicrobial stewardship
Events Partner Content BioTech Pharma Summit: Biosimilars & Biologics 2018 Biosimilars & Biologics:The future of Biotech Medicines
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
